In a nutshell This study investigated the effectiveness and side effects on the heart of anthracycline-based therapies (ABTs) for breast cancer. They found that non-doxorubicin (non-DXR) ABTs had a better benefit/risk ratio (BRR) than DXR alone. Some background Anthracycline-based therapies (ABTs) are commonly used to treat breast...
Read More
In a nutshell This study aimed to investigate zoledronic acid in combination with chemotherapy as a treatment for HER2-negative breast cancer. This study concluded that the addition of zoledronic acid to chemotherapy has potential benefits for certain breast cancer patients. Some background HER2-negative breast cancer (BC) differs from...
Read More
In a nutshell The authors aimed to determine the risk factors for patients developing a fever during chemotherapy for breast cancer. Some background Febrile neutropenia is the term that describes the development of a fever in a patient who has neutropenia; low levels of granulocytes (a type of white blood cell). This can often be caused by...
Read More
